NCT04103125View on ClinicalTrials.gov

Open, Non-Comparative Study To Evaluate The Performance Of The Medical Device JANESSE®

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

December 21, 2020

Study Completion Date

December 21, 2020

Conditions
Wrinkle
Interventions
DEVICE

Janesse® is a sterile, injectable, non-pyrogenic, re-absorbable medical product made of reticulated hyaluronic acid of non-animal origin, produced via bacterial fermentation.

The subjects will receive at baseline the first IMD by the Investigator in accordance with the CIP

Trial Locations (1)

300425

SCM Dr. Rosu, Timișoara

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

I.R.A. Istituto Ricerche Applicate S.p.A.

NETWORK

NCT04103125 - Open, Non-Comparative Study To Evaluate The Performance Of The Medical Device JANESSE® | Biotech Hunter | Biotech Hunter